The Cooper Companies, Inc. Common Stock – Quartalsabschluss (NASDAQ:COO)

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden

Vierteljährlich Jährlich

Market Capitalization 13.71 B
Employee 15 K
Founded N/A
CEO Albert G. White III
Website www.coopercos.com
Headquarter Delaware, United States
FIGI BBG000BG3445
Industry Technology

Gesamtumsatz

Jahresüberschuss

Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

13.71 B Marktkapitalisierung

Kurs-Gewinn-Verhältnis

40.12

Preis-Umsatz-Verhältnis

3.87

Dividende je Aktie

—

Dividendenrendite in %

—

The Cooper Companies Inc

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market.

COO

Financials

The Cooper Companies Inc

Nachrichten

Cooper Companies: Aktionäre wählen Direktoren und genehmigen Anträge auf Jährlicher Hauptversammlung

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Reasons to Add Cooper Companies Stock to Your Portfolio Now

Touchstone Mid Cap Fund Q4 2025 Portfolio Review

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

The Cooper Companies (COO) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term

Investing in The Cooper Companies (COO)? Don't Miss Assessing Its International Revenue Trends

Is The Cooper Companies (COO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Here's Why The Cooper Companies (COO) is a Strong Growth Stock

COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook

Cooper Companies: Needham erhöht Kursziel dank starker Margen